Willeke M C van Roon-Mom Selected Research

Neurodegenerative Diseases (Neurodegenerative Disease)

1/2023	Spinocerebellar Ataxia Type 1 Characteristics in Patient-Derived Fibroblast and iPSC-Derived Neuronal Cultures.
1/2022	Iron accumulation induces oxidative stress, while depressing inflammatory polarization in human iPSC-derived microglia.
1/2019	Generation of 5 induced pluripotent stem cell lines, LUMCi007-A and B and LUMCi008-A, B and C, from 2 patients with Huntington disease.
1/2018	Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model.
1/2017	Co-expression Patterns between ATN1 and ATXN2 Coincide with Brain Regions Affected in Huntington's Disease.
10/2016	Antisense oligonucleotide-mediated exon skipping as a strategy to reduce proteolytic cleavage of ataxin-3.
6/2015	Antisense oligonucleotides in therapy for neurodegenerative disorders.
6/2014	Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies.
1/2011	Targeting several CAG expansion diseases by a single antisense oligonucleotide.
6/2004	TBP, a polyglutamine tract containing protein, accumulates in Alzheimer's disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Willeke M C van Roon-Mom Research Topics

Disease

20	Huntington Disease (Huntington's Disease) 01/2024 - 12/2002
11	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 08/2023 - 06/2003
11	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 12/2002
8	Disease Progression 04/2022 - 06/2015
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 12/2002
5	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2022 - 01/2014
4	Familial Cerebral Amyloid Angiopathy 11/2019 - 01/2014
4	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 01/2018 - 10/2013
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 01/2018
2	Inflammation (Inflammations) 01/2022 - 01/2022
2	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 01/2017 - 01/2011
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 06/2015 - 01/2011
2	Atrophy 07/2012 - 06/2004
1	Seizures (Absence Seizure) 01/2024
1	Glut1 Deficiency Syndrome 11/2023
1	Epilepsy (Aura) 11/2023
1	Ataxia (Dyssynergia) 08/2023
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Brain Diseases (Brain Disorder) 01/2022
1	Propionic Acidemia 12/2020
1	Metabolic Diseases (Metabolic Disease) 12/2020
1	Spinal Diseases (Disease, Spinal) 01/2018
1	Muscular Atrophy (Muscle Atrophy) 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Pheochromocytoma 12/2017
1	X-Linked Bulbo-Spinal Atrophy 01/2017
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2017
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 06/2015
1	Rupture 01/2014
1	Hemorrhage 01/2014
1	Infarction (Infarctions) 01/2014
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2014
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 03/2011
1	Muscular Dystrophies (Muscular Dystrophy) 03/2011
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2011
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2011
1	Nervous System Diseases (Neurological Disorders) 12/2002
1	Parkinson Disease (Parkinson's Disease) 12/2002
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 12/2002

Drug/Important Bio-Agent (IBA)

18	polyglutamineIBA 01/2023 - 12/2002
8	Amyloid (Amyloid Fibrils)IBA 01/2022 - 12/2002
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2002
6	Antisense OligonucleotidesIBA 01/2022 - 01/2011
6	Huntingtin ProteinIBA 01/2022 - 12/2002
5	RNA (Ribonucleic Acid)IBA 08/2023 - 06/2014
5	Biomarkers (Surrogate Marker)IBA 04/2022 - 10/2015
5	Ataxin-3IBA 01/2018 - 01/2011
3	Ataxin-1IBA 01/2023 - 01/2011
3	IronIBA 01/2022 - 07/2012
3	Adenine FDA LinkGeneric 10/2018 - 01/2017
3	GuanineIBA 10/2018 - 01/2017
3	CytosineIBA 10/2018 - 01/2017
3	tributyl phosphate (TBP)IBA 01/2017 - 06/2003
2	Amyloid beta-PeptidesIBA 01/2022 - 06/2004
2	Protein AggregatesIBA 01/2019 - 04/2006
2	Adenosine Triphosphate (ATP)IBA 10/2018 - 01/2018
2	Amino Acids FDA Link 01/2018 - 12/2002
2	Messenger RNA (mRNA)IBA 01/2011 - 10/2008
2	TATA-Box Binding Protein (TATA-Binding Protein)IBA 06/2003 - 12/2002
1	CORT113176IBA 01/2024
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2024
1	Glucose (Dextrose)FDA LinkGeneric 11/2023
1	AMPA Receptors (AMPA Receptor)IBA 01/2023
1	ElementsIBA 01/2023
1	ParvalbuminsIBA 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Ferritins (Ferritin)IBA 01/2022
1	6-propylchromone-2-carboxylic acid (PCCA)IBA 12/2020
1	OsteopontinIBA 11/2019
1	Peptides (Polypeptides)IBA 01/2018
1	nusinersenIBA 01/2018
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	Tryptophan (L-Tryptophan)FDA Link 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	CeramidesIBA 01/2018
1	CarbonIBA 01/2018
1	Transforming Growth Factor-beta Type II ReceptorIBA 01/2018
1	Doxycycline (Periostat)FDA LinkGeneric 12/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Ataxia Telangiectasia Mutated ProteinsIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 10/2015
1	Single-Domain AntibodiesIBA 03/2015
1	Mutant Proteins (Protein, Mutant)IBA 10/2013
1	RNA Precursors (Precursor, mRNA)IBA 01/2011
1	atrophin-1IBA 01/2011
1	Dopamine (Intropin)FDA LinkGeneric 10/2008

Therapy/Procedure

7	Therapeutics 08/2023 - 01/2011